Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00405834 · ClinicalTrials.gov registry record
A Pilot Study of the Envision® Surface
A clinical trial, sponsored by Hill-Rom.
- Completed
- Registry status
- 30
- Enrollment target
NCT00405834: Completed study, sponsored by Hill-Rom.
NCT00405834 is a clinical trial that has completed, run by Hill-Rom. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00405834 has completed, sponsored by Hill-Rom.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study is to evaluate the clinical safety and effectiveness of the Envision® surface.
Interventions
- DEVICE Envision® Patient Support System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-06 |
| Est. Completion | 2007-10 |
What the finished NCT00405834 record still lists
NCT00405834 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Envision® Patient Support System is the first listed.
NCT00405834 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00405834 about?
NCT00405834 is a clinical study titled "A Pilot Study of the Envision® Surface". This study is to evaluate the clinical safety and effectiveness of the Envision® surface.
What is the current status of trial NCT00405834?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2007-06. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00405834?
The interventions under investigation include: Envision® Patient Support System (DEVICE).
Who is sponsoring clinical trial NCT00405834?
This trial is sponsored by Hill-Rom, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia